The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial–mesenchymal transition by phosphorylating β-catenin

Jingyao Ruan,Qi Tian,Siting Li,Xiaoyu Zhou,Qianzhi Sun,Yuning Wang,Yinping Xiao,Mingqing Li,Kaikai Chang,Xiaofang Yi

DOI: https://doi.org/10.1186/s12964-024-01683-x

IF: 7.525

2024-06-12

Cell Communication and Signaling

Abstract:Interleukin 33 (IL-33) is a crucial inflammatory factor that functions as an alarm signal in endometriosis (EMs). Epithelial-mesenchymal transition (EMT), a process related to inflammatory signals, intracellular reactive oxygen species (ROS) production, and lipid peroxidation, have been proposed as potential mechanisms that contribute to the development and progression of EMs. IL-33 is highly upregulated in the ectopic milieu. Moreover, ectopic endometrial cells constitutively express interleukin-33 receptor ST2 (IL-33R). However, the role of IL-33/ST2 in the EMT of EMs remains largely unknown. In this study, we aimed to mechanistically determine the role of IL-33/ST2 in EMs-associated fibrosis.

cell biology

What problem does this paper attempt to address?

This paper primarily explores the mechanism of action of interleukin-33 (IL-33) and its receptor ST2 in endometriosis (EMs), particularly how they participate in the formation of fibrosis by promoting the epithelial-mesenchymal transition (EMT) process. ### Research Questions The key questions the paper attempts to answer are: - Does the IL-33/ST2 axis play a critical role in the fibrosis process associated with endometriosis? - How does the IL-33/ST2 axis promote epithelial-mesenchymal transition (EMT) by regulating the phosphorylation of β-catenin, thereby affecting the development of endometriosis? ### Main Findings - The level of IL-33 is significantly elevated in the peritoneal fluid of endometriosis patients. - Oxidative stress environment, high concentrations of transforming growth factor β1 (TGF-β1), and estradiol (E2) can trigger the secretion of IL-33 in the endometriosis environment. - IL-33 can enhance the migration and survival of endometrial stromal cells (ESCs), and this effect is dependent on the presence of ST2. - IL-33 promotes the expression of EMT-related genes, such as CCN4 and Fra-1, by activating the Wnt/β-catenin signaling pathway. - Blocking IL-33 or its receptor ST2 can inhibit the EMT process and reduce the occurrence of endometriosis-associated fibrosis. - Animal experiments further confirmed that IL-33 can significantly promote the fibrosis process associated with endometriosis. ### Conclusion The research results support that the IL-33/ST2 axis plays an important role in endometriosis-associated fibrosis and highlight the importance of EMT in the pathophysiology of this disease. Targeting the IL-33/ST2/Wnt/β-catenin axis may be a feasible therapeutic strategy for controlling endometriosis fibrosis.

The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial–mesenchymal transition by phosphorylating β-catenin

Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis Through CSF1R/JAK3/STAT6 Signaling

Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion.

Hypoxia Promotes Ectopic Adhesion Ability of Endometrial Stromal Cells Via TGF-β1/Smad Signaling in Endometriosis

Role of Interleukin-6 and Its Receptor in Endometriosis.

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

Nlrp3 Inflammasome Activation Of Mast Cells By Estrogen Via The Nuclear-Initiated Signaling Pathway Contributes To The Development Of Endometriosis

Interleukin-33 Derived from Endometriotic Lesions Promotes Fibrogenesis through Inducing the Production of Profibrotic Cytokines by Regulatory T Cells

The role of miR-34c-5p/Notch in epithelial-mesenchymal transition (EMT) in endometriosis

Exosomes from the Uterine Cavity Mediate Immune Dysregulation via Inhibiting the JNK Signal Pathway in Endometriosis

Interleukin-33 Predicts Poor Prognosis and Promotes Ovarian Cancer Cell Growth and Metastasis Through Regulating Erk and Jnk Signaling Pathways

Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy

IL-27 Triggers IL-10 Production in Th17 Cell by C-Maf/rorγt/blimp-1 Signal to Promote the Progress of Endometriosis

IL-27 triggers IL-10 production in Th17 cells via a c-Maf/ROR γ t/Blimp-1 signal to promote the progression of endometriosis

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Reduced Expression of Eukaryotic Translation Initiation Factor 3 Subunit E and Its Possible Involvement in the Epithelial-Mesenchymal Transition in Endometriosis

Macrophages originated IL-33/ST2 inhibits ferroptosis in endometriosis via the ATF3/SLC7A11 axis

Long Non Coding RNA, C8orf49, a Novel Diagnostic and Prognostic Biomarker, Enhances PTEN/FZD4-mediated Cell Growth and Metastasis by Sponging Mir-1323 in Endometriosis.

MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro

IL-33 Enhances Proliferation and Invasiveness of Decidual Stromal Cells by Up-Regulation of CCL2/CCR2 Via NF-κB and ERK1/2 Signaling.

Gut Microbiota Disorder Contributes to the Production of IL-17A That Exerts Chemotaxis via Binding to IL-17RA in Endometriosis